Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Total Liabilities (2018 - 2025)

Historic Total Liabilities for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to $6.0 million.

  • Nexgel's Total Liabilities rose 819.91% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 819.91%. This contributed to the annual value of $4.9 million for FY2024, which is 238.05% up from last year.
  • According to the latest figures from Q3 2025, Nexgel's Total Liabilities is $6.0 million, which was up 819.91% from $4.7 million recorded in Q2 2025.
  • Over the past 5 years, Nexgel's Total Liabilities peaked at $6.0 million during Q3 2025, and registered a low of $2.4 million during Q1 2021.
  • Its 5-year average for Total Liabilities is $4.3 million, with a median of $4.5 million in 2021.
  • Per our database at Business Quant, Nexgel's Total Liabilities surged by 14355.19% in 2021 and then crashed by 4446.71% in 2022.
  • Quarter analysis of 5 years shows Nexgel's Total Liabilities stood at $4.9 million in 2021, then plummeted by 44.47% to $2.7 million in 2022, then skyrocketed by 76.07% to $4.8 million in 2023, then increased by 2.38% to $4.9 million in 2024, then increased by 23.27% to $6.0 million in 2025.
  • Its Total Liabilities stands at $6.0 million for Q3 2025, versus $4.7 million for Q2 2025 and $4.9 million for Q1 2025.